PT  - JOURNAL ARTICLE
AU  - Invernizzi, Azzurra
AU  - Rechtman, Elza
AU  - Curtin, Paul
AU  - Papazaharias, Demetrios M.
AU  - Jalees, Maryam
AU  - Pellecchia, Alison C.
AU  - Bromet, Evelyn J.
AU  - Lucchini, Roberto G.
AU  - Luft, Benjamin J.
AU  - Clouston, Sean A.
AU  - Tang, Cheuk Y.
AU  - Horton, Megan K.
TI  - Functional changes in neural mechanisms underlying post-traumatic stress disorder in World Trade Center responders
AID  - 10.1101/2022.04.05.22273447
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.04.05.22273447
4099  - http://medrxiv.org/content/early/2022/04/07/2022.04.05.22273447.short
4100  - http://medrxiv.org/content/early/2022/04/07/2022.04.05.22273447.full
AB  - World Trade Center (WTC) responders exposed to traumatic and environmental stressors during rescue and recovery efforts have higher prevalence (23%) of persistent, clinically significant WTC-related post-traumatic stress disorder (WTC-PTSD). Here, we applied eigenvector centrality (EC) metrics and data driven methods on resting state functional magnetic resonance (fMRI) outcomes to investigate neural mechanisms underlying WTC-PTSD and to identify how EC shifts in brain areas relate to WTC-exposure and behavioral symptoms. Nine brain areas differed significantly and contributed the most to differentiate functional neuro-profiles between WTC-PTSD and non-PTSD responders. The association between WTC-exposure and EC values differed significantly between WTC-PTSD and non-PTSD in the right anterior parahippocampal gyrus and left amygdala (p= 0.010; p= 0.005, respectively, adjusted for multiple comparisons). Within WTC-PTSD, the index of PTSD symptoms was positively associated with EC values in the right anterior parahippocampal gyrus and brainstem. Our understanding of functional changes in neural mechanisms underlying WTC-related PTSD is key to advance intervention and treatment.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors would like to acknowledge support from the Centers for Disease Control and Prevention for supporting the neuroimaging study (CDC/NIOSH U01 OH011314) the National Institute on Aging that supports research on characterization and treatment of Alzheimer disease (NIH/NIA P50 AG005138) and aging-relates work in this population (NIH/NIA R01 AG049953) We would also like to acknowledge ongoing funding to monitor World Trade Center responders as part of the WTC Health and Wellness Program (CDC 200-2011-39361)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Study procedures that follow the Declaration of Helsinki, were approved by the Institutional Review Boards at both Stony Brook University and the Icahn School of Medicine at Mount SinaiI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors